BCLP Partner David B. Schwartz Comments in Law360 on Federal Circuit's Orange Book Ruling
January 16, 2025
January 16, 2025
ST. LOUIS, Missouri, Jan. 16 -- Bryan Cave Leighton Paisner, a law firm, issued the following news:
BCLP Partner David B. Schwartz commented in Law360 on the Federal Circuit's recent decision regarding the Orange Book, a key list maintained by the U.S. Food and Drug Administration (FDA) that includes patents associated with approved drug products.
The former Lead Investigative Attorney at the U.S. Federal Trade Commission (FTC) noted, "This has been an issue t . . .
BCLP Partner David B. Schwartz commented in Law360 on the Federal Circuit's recent decision regarding the Orange Book, a key list maintained by the U.S. Food and Drug Administration (FDA) that includes patents associated with approved drug products.
The former Lead Investigative Attorney at the U.S. Federal Trade Commission (FTC) noted, "This has been an issue t . . .